Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Clinical Trial

Eating Only Two Meals a Day Changes Your Metabolism, Here Is What Happens Over Time

Your Hunger Hormones Shift FirstWithin the first week of eating only two meals a day, ghrelin, the hormone that triggers hunger, begins to recalibrate its peak times. Instead of spiking at your old breakfast hour, it gradually aligns with your new first meal window. A 2019 study published in Obesity…

Times Life

Brexit denies UK children access to life-extending drug for aggressive brain cancer

Exclusive: Experts say Brexit has led to delays in the launch of clinical trials and increased costs for multiple drugs. They are urging the government to reset the UK’s relationship with Europe to reopen access to potentially life-changing treatments

The Independent UK

How Poor Dental Health Slowly Destroys Your Gut Microbiome and Digestion Over Time

Your mouth is your gut's front doorThe average adult swallows roughly 1.5 litres of saliva every day. Every millilitre carries millions of microorganisms. When your oral microbiome is balanced, that constant swallowing is harmless, most oral bacteria are acid-sensitive and die in the stomach. When your mouth is colonised by…

Times Life

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca Shares Sink After Heart Drug Trial Miss. Rare Clinical Setback Tests Investor Confidence

AstraZeneca shares fell sharply Thursday after the pharmaceutical giant reported that its experimental use of Wainua failed to achieve the primary endpoint in a late-stage clinical trial for a rare heart disease.

International Business Times

A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results

A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline.

Medical Daily

Global Market: European shares rebound as tech stocks recover; investors assess Middle East developments

European stock markets traded higher on Thursday, recovering from previous losses. Technology shares led the gains, driven by renewed interest in artificial intelligence demand. Oil prices eased despite ongoing geopolitical uncertainty in the Middle East region. Spanish equities outperformed regional peers after trade-related tensions eased. AstraZeneca shares tumbled significantly after…

The Economic Times

GLP-1 Drugs Are Now Being Tested Alongside Chemotherapy in Cancer Patients

A University of Arizona trial is testing GLP-1 drugs with chemotherapy in metastatic pancreatic, colorectal, and liver cancer patients. Here's what the study asks.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

What the Thirukkural Says About Gratitude and the Daily Practice That Takes 60 Seconds

The kural that started with a mustard seedKural 108 is the one most people quote without knowing its number. Valluvar writes that a favour done in a moment of need, even if it is as small as a mustard seed, should be seen by the receiver as large as a…

Times Life

The Clinical Trial That Supported Tavneos for ANCA Vasculitis Was Just Retracted

NEJM retracted the Tavneos ADVOCATE trial on June 29, 2026, after FDA found altered patient data. Patients should not stop Tavneos without a doctor — here's what's known.

Medical Daily

New drug for cancer patients with ‘limited’ treatment options enters clinical trial

Scientists have expressed ‘excitement’ over the potential new treatment for advanced adrenocortical carcinoma (ACC)

The Independent UK

Scientists Used Vitamin B12 to Sneak a Cancer-Killer into the Brain, and It Worked on Tumors in Animal Studies

A new Oncoscience study found a vitamin B12-based compound crosses the blood-brain barrier, targets glioblastoma tumors, and boosts treatment effects in animal models.

Medical Daily

DRC trials experimental treatment for rare Ebola strain as outbreak worsens

The Democratic Republic of Congo has launched a clinical trial of experimental Ebola treatments as the outbreak continues to spread in the north-east of the country.

Radio France Internationale

Scientists Found an Unexpected Way to Make Pancreatic Cancer Cells Destroy Themselves

New research published June 29, 2026, found compounds triggering self-destruction in pancreatic cancer cells. One blocked 90% of cancer spread in lab models. What it means.

Medical Daily

An Oral Antibiotic Pill Proved Just as Effective as IV Treatment for Drug-Resistant UTIs

A clinical trial found oral fosfomycin as effective as IV carbapenem for drug-resistant UTIs from ESBL bacteria. Here's what the finding means for patients and prescribers.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Seniors Taking Antidepressants May Benefit from Adding a Daily Probiotic, New Clinical Trial Finds

A June 2026 clinical trial found seniors with depression who added a daily probiotic to antidepressants improved more than those on placebo. Here's what the research actually shows.

Radio France Internationale

US releases experimental Ebola drug for DR Congo outbreak trials

Experimental Ebola drugs are being shipped to Democratic Republic of Congo as the United States releases doses of a treatment for clinical trials in a widening outbreak that has caused more than 1,000 cases and over 250 deaths, the World Health Organization and US officials have said.

Medical Daily

Daily Pill Cuts Sleep Apnea Breathing Pauses by 47% in Lancet Clinical Trial, Offering Hope for Alternative Treatment

A Lancet clinical trial of 298 adults with moderate-to-severe sleep apnea found sulthiame reduced breathing interruptions by up to 47% with improved oxygen levels overnight.

Medical Daily

University of Florida Study Warns Glucosamine Users After Finding Link to 25% Faster Alzheimer's Disease Progression

University of Florida study in Nature Metabolism, June 9, 2026: glucosamine use linked to 25% faster MCI-to-Alzheimer's progression. What elderly supplement users need to know.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Clinical Trial: Adding a Daily Probiotic to Antidepressant Treatment Reduced Depression and Anxiety in Older Adults

JAGS clinical trial June 17, 2026: 58 older adults adding daily probiotics to antidepressants showed meaningful depression and anxiety reductions vs. placebo over 12 weeks.

MyLifeXP

Could a Simple Blood Test Stop Lung Cancer Early?

What if a simple blood test could tell you that lung cancer might develop years before it actually appears? It sounds like science fiction, but researchers believe it could soon become reality. A groundbreaking study has identified a unique set of proteins in the blood that may reveal a person's…

TechRadar

Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trials data breached

The company says the data is pseudonymous and apparently can't be linked to actual people.

The Guardian - US

Autistic children being injected with unapproved stem cell treatments supported by RFK Jr

Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus

AAP

ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens

JENA, Germany, June 11, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today the successful early clinical implantations of the ZEISS AT LUCIA toric 721P intraocular lens (IOL), designed to treat cataracts while simultaneously correcting astigmatism. ZEISS is currently conducting an early-access clinical trial with a select group of highly experienced…

Medical Daily

Chicago's VA Hospital Just Enrolled Its First Veterans in a Psilocybin-Assisted Therapy Program — And the Science Behind Their PTSD Treatment Is Changing Psychiatry

A new VA clinical trial in Chicago is testing psilocybin-assisted therapy for treatment-resistant PTSD, offering hope to veterans.

The Economic Times

Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip race

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after completing clinical trials. Developed by Tsinghua University and Neuracle Technology, the less invasive implant aims to aid individuals with paralysis and spinal cord injuries, marking a significant milestone ahead of Elon…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

University of Florida

132 stories

UC Davis

127 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Democratic Republic of Congo

553 stories

the Democratic Republic of Congo

324 stories

Jena

13 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.